Press Releases

RESEARCH TRIANGLE PARK, N.C. --(BUSINESS WIRE)--Jul. 24, 2018-- TransEnterix, Inc. (NYSE American:TRXC) announced today that it plans to release second quarter 2018 financial and operating results before the market opens on Tuesday, August 7, 2018 . Todd M.

Announces fourth Senhance System sale in second quarter of 2018 Preliminary unaudited revenue of $6.0 - $6.3 million for second quarter of 2018 Received FDA clearance for expanded indications for use for Senhance System Filed FDA 510(k) submission for additional Senhance System Instruments

RESEARCH TRIANGLE PARK, N.C. --(BUSINESS WIRE)--Jun. 25, 2018-- TransEnterix, Inc. (NYSE American:TRXC), a medical device company that is digitizing the interface between surgeons and patients to improve minimally invasive surgery, today announced that the company will be added to the Russell 2000

Filed 510(k) submission for 3mm Instruments, advancing minimally invasive capabilities within digital laparoscopy RESEARCH TRIANGLE PARK, N.C. --(BUSINESS WIRE)--Jun. 7, 2018-- TransEnterix, Inc. (NYSE American:TRXC), a medical device company that is digitizing the interface between surgeons and

RESEARCH TRIANGLE PARK, N.C. --(BUSINESS WIRE)--May 31, 2018-- TransEnterix, Inc. (NYSE American:TRXC), a medical device company that is digitizing the interface between the surgeon and the patient to improve minimally invasive surgery, today announced that LSU Health completed the purchase of the

Receives FDA 510(k) clearance for laparoscopic inguinal hernia and laparoscopic cholecystectomy procedures Doubles total addressable market in the U.S. to over three million annual procedures RESEARCH TRIANGLE PARK, N.C. --(BUSINESS WIRE)--May 29, 2018-- TransEnterix, Inc.

--- Non-dilutive financing extends cash reach to over two years --- RESEARCH TRIANGLE PARK, N.C. --(BUSINESS WIRE)--May 23, 2018-- TransEnterix, Inc. (NYSE American: TRXC) (the “Company”), a medical device company that is digitizing the interface between the surgeon and the patient to improve

RESEARCH TRIANGLE PARK, N.C. --(BUSINESS WIRE)--May 8, 2018-- TransEnterix, Inc. (NYSE American:TRXC), a medical device company that is digitizing the interface between the surgeon and the patient to improve minimally invasive surgery, today announced its operating and financial results for the

RESEARCH TRIANGLE PARK, N.C. --(BUSINESS WIRE)--Apr. 24, 2018-- TransEnterix, Inc. (NYSE American:TRXC) announced today that it plans to release first quarter 2018 financial and operating results after the market closes on Tuesday, May 8, 2018 . Todd M.

RESEARCH TRIANGLE PARK, N.C. --(BUSINESS WIRE)--Apr. 4, 2018-- TransEnterix, Inc. (NYSE American: TRXC), a medical device company that is digitizing the interface between the surgeon and the patient to improve minimally invasive surgery, will showcase the Senhance™ Surgical System at the 16th World